PTM MAPPING IN HUMAN H-RAS UNDER OXIDATIVE STRESSES
氧化应激下人类 H-RAS 的 PTM 作图
基本信息
- 批准号:8170941
- 负责人:
- 金额:$ 4.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-06-01 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdenovirusesCell LineCell ProliferationCell membraneCleaved cellComputer Retrieval of Information on Scientific Projects DatabaseCysteineDialysis procedureDigestionEndothelial CellsFourier transform ion cyclotron resonanceFundingGelGrantGuanosine Triphosphate PhosphohydrolasesHRAS geneHigh Pressure Liquid ChromatographyHumanInstitutionMagnetismMapsMass Spectrum AnalysisMethodsModificationOxidative StressPeptidesPolyethylene GlycolsPost-Translational Protein ProcessingProteinsProtocols documentationRecoveryResearchResearch PersonnelResourcesSamplingSignal TransductionSourceUnited States National Institutes of Healthinterestprotein functionresearch study
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
H-Ras is a plasma membrane associated GTPase, which is an important player in signal transduction to control cell proliferation, differentiation, and invasion. There are four reactive cysteines (C118, C181, C184 and C186) on H-Ras. These cysteines are targets of posttranslational modifications (PTM) which may alter the cellular localization and function of this protein. In this study, PTMs on H-Ras in human aortic endothelial cells (HAECs) is being investigated by mass spectrometry to obtain the full map of H-Ras modifications under different oxidative stresses.
H-Ras is not an abundant protein that can be easily extracted from cell lines. A protocol has been developed to facilitate the enrichment and purification of the H-Ras, where exogenous H-Ras with 6X His tag was transduced by adenovirus, and pulled down by magnetic Ni-NTA beads. Tryptic in-gel digestion was performed on the His-tagged H-Ras, followed by MS analysis using both MALDI-TOF and LTQ-Orbitrap. Although high sequence coverage was obtained by combining these two methods, only C181 and C184 containing peptides were identified in the mass spectrum. The C186 containing tryptic peptide CVLS was absent in either experiment, because VLS is known to be cleaved after C186 gets farnesylated.
Since two cysteine residues of interest were not covered in the bottom-up analysis, a top-down approach by Fourier-transform ion cyclotron resonance (FT-ICR) MS is now being developed. Several methods have been tried for the purification of the H-Ras sample, including those that use the Ziptip (C4 and C18) or centrifugal filters, dialysis, and the CapLC. It was found that the combination of dialysis and use of the Poros 50 R1 column provides the best result with the highest protein recovery yield and least interference from polyethylene glycol (PEG) and other undesirable contaminants. HPLC and Michrom desalting trap will be tried next.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
H-Ras是一种质膜相关的GT3,在细胞增殖、分化和侵袭的信号转导中起重要作用。在H-Ras上有四个反应性半胱氨酸(C118、C181、C184和C186)。这些半胱氨酸是翻译后修饰(PTM)的靶标,其可以改变该蛋白质的细胞定位和功能。在这项研究中,PTMs对H-Ras在人主动脉内皮细胞(HAECs)正在研究通过质谱法获得不同的氧化应激下的H-Ras修饰的完整地图。
H-Ras不是一种可以容易地从细胞系中提取的丰富蛋白。已经开发了一种方案来促进H-Ras的富集和纯化,其中具有6X His标签的外源H-Ras通过腺病毒转导,并通过磁性Ni-NTA珠拉下。对His标记的H-Ras进行胰蛋白酶凝胶内消化,然后使用MALDI-TOF和LTQ-Orbitrap进行MS分析。虽然通过结合这两种方法获得了高的序列覆盖率,但在质谱中仅鉴定出含有C181和C184的肽。在任一实验中不存在含有C186的胰蛋白酶肽CVLS,因为已知VLS在C186被法尼基化后被切割。
由于自下而上的分析没有涵盖两个感兴趣的半胱氨酸残基,因此现在正在开发一种通过傅里叶变换离子回旋共振(FT-ICR)MS的自上而下的方法。已经尝试了几种方法来纯化H-Ras样品,包括使用Ziptip(C4和C18)或离心过滤器、透析和CapLC的那些。结果发现,透析和使用波罗斯50 R1色谱柱的组合提供了最佳结果,具有最高的蛋白质回收率和最少的聚乙二醇(PEG)和其他不良污染物干扰。接下来将尝试HPLC和Michrom反相器。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD A COHEN其他文献
RICHARD A COHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD A COHEN', 18)}}的其他基金
ID OF OXIDANT SENSITIVE CYSTEINE CONTAINING PROTEINS BY MASS SPECTROMETRY
通过质谱法鉴定含氧化剂敏感半胱氨酸的蛋白质
- 批准号:
8365499 - 财政年份:2011
- 资助金额:
$ 4.05万 - 项目类别:
PTM MAPPING IN HUMAN H-RAS UNDER OXIDATIVE STRESSES
氧化应激下人类 H-RAS 的 PTM 作图
- 批准号:
8365567 - 财政年份:2011
- 资助金额:
$ 4.05万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8109964 - 财政年份:2010
- 资助金额:
$ 4.05万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8484428 - 财政年份:2010
- 资助金额:
$ 4.05万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
7947453 - 财政年份:2010
- 资助金额:
$ 4.05万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8149954 - 财政年份:2010
- 资助金额:
$ 4.05万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8294637 - 财政年份:2010
- 资助金额:
$ 4.05万 - 项目类别:
Aortic Stiffness and Hypertension in Obese Mice
肥胖小鼠的主动脉僵硬和高血压
- 批准号:
8292165 - 财政年份:2010
- 资助金额:
$ 4.05万 - 项目类别:
Redox Regulation of p21ras in Angiogenesis
p21ras 在血管生成中的氧化还原调节
- 批准号:
8699256 - 财政年份:2010
- 资助金额:
$ 4.05万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 4.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 4.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 4.05万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 4.05万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 4.05万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 4.05万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 4.05万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 4.05万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 4.05万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 4.05万 - 项目类别:
Studentship